General Information of the Compound
| Compound ID |
CP0410312
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
4-[2-[(2R)-2-[(E,3S)-3-hydroxy-4-[3-(pyridin-2-ylmethoxy)phenyl]but-1-enyl]-5-oxopyrrolidin-1-yl]ethylsulfanyl]butanoic acid
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C26H32N2O5S
|
||||||||||||||||||
| Molecular Weight |
484.618
|
||||||||||||||||||
| Canonical SMILES |
O[C@@H](Cc1cccc(OCc2ccccn2)c1)\C=C\[C@H]1CCC(=O)N1CCSCCCC(O)=O
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C26H32N2O5S/c29-23(17-20-5-3-7-24(18-20)33-19-21-6-1-2-13-27-21)11-9-22-10-12-25(30)28(22)14-16-34-15-4-8-26(31)32/h1-3,5-7,9,11,13,18,22-23,29H,4,8,10,12,14-17,19H2,(H,31,32)/b11-9+/t22-,23+/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
YVLSZAQQNSHRAV-RBJONROZSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02988, Prostaglandin E2 receptor EP1 subtype
Protein ID: PT02989, Prostaglandin E2 receptor EP2 subtype
Protein ID: PT02345, Prostaglandin E2 receptor EP3 subtype
Protein ID: PT04548, Prostaglandin E2 receptor EP4 subtype
Protein ID: PT02346, Prostaglandin E2 receptor EP4 subtype